These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29499749)

  • 1. Barriers, supports, and effective interventions for uptake of human papillomavirus- and other vaccines within global and Canadian Indigenous peoples: a systematic review protocol.
    Mrklas KJ; MacDonald S; Shea-Budgell MA; Bedingfield N; Ganshorn H; Glaze S; Bill L; Healy B; Healy C; Guichon J; Colquhoun A; Bell C; Richardson R; Henderson R; Kellner J; Barnabe C; Bednarczyk RA; Letendre A; Nelson GS
    Syst Rev; 2018 Mar; 7(1):40. PubMed ID: 29499749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First nations people's perspectives on barriers and supports for enhancing HPV vaccination: Foundations for sustainable, community-driven strategies.
    Henderson RI; Shea-Budgell M; Healy C; Letendre A; Bill L; Healy B; Bednarczyk RA; Mrklas K; Barnabe C; Guichon J; Bedingfield N; MacDonald S; Colquhoun A; Glaze S; Nash T; Bell C; Kellner J; Richardson R; Dixon T; Starlight J; Runner G; Nelson G
    Gynecol Oncol; 2018 Apr; 149(1):93-100. PubMed ID: 29605057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV vaccine: uptake and understanding among global Indigenous communities - a qualitative systematic review.
    Poirier B; Sethi S; Garvey G; Hedges J; Canfell K; Smith M; Ju X; Jamieson L
    BMC Public Health; 2021 Nov; 21(1):2062. PubMed ID: 34758805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
    Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Group Knowledge, Perceptions and Behaviors about Human Papillomavirus, Human Papillomavirus Vaccination, and Cervical Cancer among Adolescent Females.
    Bond SM; Cartmell KB; Lopez CM; Ford ME; Brandt HM; Gore EI; Zapka JG; Alberg AJ
    J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):429-435. PubMed ID: 26915922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and supports for uptake of human papillomavirus vaccination in Indigenous people globally: A systematic review.
    MacDonald SE; Kenzie L; Letendre A; Bill L; Shea-Budgell M; Henderson R; Barnabe C; Guichon JR; Colquhoun A; Ganshorn H; Bedingfield N; Vandenboogaard PD; Bednarczyk RA; Glaze S; Nelson G
    PLOS Glob Public Health; 2023; 3(1):e0001406. PubMed ID: 36962871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
    Lim ASE; Lim RBT
    Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis.
    Ferrer HB; Trotter C; Hickman M; Audrey S
    BMC Public Health; 2014 Jul; 14():700. PubMed ID: 25004868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communication around HPV vaccination for adolescents in low- and middle-income countries: a systematic scoping overview of systematic reviews.
    Foss HS; Oldervoll A; Fretheim A; Glenton C; Lewin S
    Syst Rev; 2019 Aug; 8(1):190. PubMed ID: 31370886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of HPV vaccination among young adults: a qualitative systematic review and evidence synthesis protocol.
    Mantina NM; Nakayima Miiro F; Smith J; McClelland DJ; Magrath PA; Madhivanan P
    BMJ Open; 2023 Dec; 13(12):e076234. PubMed ID: 38072486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.
    Holman DM; Benard V; Roland KB; Watson M; Liddon N; Stokley S
    JAMA Pediatr; 2014 Jan; 168(1):76-82. PubMed ID: 24276343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda.
    Ngcobo NJ; Burnett RJ; Cooper S; Wiysonge CS
    S Afr Med J; 2018 Dec; 109(1):13-15. PubMed ID: 30606297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to improve human papillomavirus vaccination among Chinese female college students: study protocol for a randomized controlled trial.
    Si M; Su X; Jiang Y; Qiao Y; Liu Y
    BMC Public Health; 2019 Nov; 19(1):1546. PubMed ID: 31752785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study protocol:
    Whop LJ; Butler TL; Brotherton JML; Anderson K; Cunningham J; Tong A; Garvey G
    BMJ Open; 2021 Aug; 11(8):e047890. PubMed ID: 34344679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, perceptions, and decision making about human papillomavirus vaccination among Korean American women: a focus group study.
    Kim K; Kim B; Choi E; Song Y; Han HR
    Womens Health Issues; 2015; 25(2):112-9. PubMed ID: 25747518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol.
    Palmer M; Katanoda K; Saito E; Martellucci CA; Ostuki S; Nomura S; Ota E; Brotherton JML; Hocking J
    Syst Rev; 2021 May; 10(1):135. PubMed ID: 33952342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the barriers to HPV vaccination in high-risk populations in the US.
    Downs LS; Scarinci I; Einstein MH; Collins Y; Flowers L
    Gynecol Oncol; 2010 Jun; 117(3):486-90. PubMed ID: 20303156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing HPV vaccine implementation in South Asia: a scoping review protocol.
    Rajkhowa P; Pundir P; Dsouza SM; Patil DS; Narayanan P; Brand H
    Syst Rev; 2024 Jan; 13(1):14. PubMed ID: 38178265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review.
    Peterson CE; Silva A; Holt HK; Balanean A; Goben AH; Dykens JA
    Cancer Causes Control; 2020 Sep; 31(9):801-814. PubMed ID: 32537702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.